@article{a6258e845f7e43a988005f7ef59628a6,
title = "Hippocampal synaptic dysfunction in the SOD1G93A mouse model of Amyotrophic Lateral Sclerosis: reversal by adenosine A2AR blockade",
abstract = "Amyotrophic Lateral Sclerosis (ALS) mostly affects motor neurons, but non-motor neural and cognitive alterations have been reported in ALS mouse models and patients. Here, we evaluated if time-dependent biphasic changes in synaptic transmission and plasticity occur in hippocampal synapses of ALS SOD1 G93A mice. Recordings were performed in hippocampal slices of SOD1 G93A and age-matched WT mice, in the pre-symptomatic and symptomatic stages. We found an enhancement of pre-synaptic function and increased adenosine A 2A receptor levels in the hippocampus of pre-symptomatic mice. In contrast, in symptomatic mice, there was an impairment of long-term potentiation (LTP) and a decrease in NMDA receptor-mediated synaptic currents, with A 2AR levels also being increased. Chronic treatment with the A 2AR antagonist KW-6002, rescued LTP and A 2AR values. Altogether, these findings suggest an increase in synaptic function during the pre-symptomatic stage, followed by a decrease in synaptic plasticity in the symptomatic stage, which involves over-activation of A 2AR from early disease stages.",
keywords = "A receptor, ALS, Hippocampus, KW-6002, Long-term potentiation (LTP), NMDA receptor, Neuronal plasticity",
author = "N. Rei and Rombo, {D. M.} and Ferreira, {M. F.} and Y. Baqi and M{\"u}ller, {C. E.} and Ribeiro, {J. A.} and Sebasti{\~a}o, {A. M.} and Vaz, {S. H.}",
note = "Funding Information: This research was supported by UID/BIM/50005/2019, project funded by Funda{\c c}{\~a}o para a Ci{\^e}ncia e a Tecnologia (FCT) / Minist{\'e}rio da Ci{\^e}ncia, Tecnologia e Ensino Superior (MCTES) through Fundos do Or{\c c}amento de Estado , by PTDC/BTM-SAL/32147/2017 (FCT) and by a Twinning action (SynaNet) from the EU H2020 programme (project number: 692340 ). N.R. was in receipt of an FCT PhD fellowship (PD/BD/113463/2015). Funding Information: This research was supported by UID/BIM/50005/2019, project funded by Funda{\c c}{\~a}o para a Ci{\^e}ncia e a Tecnologia (FCT)/Minist{\'e}rio da Ci{\^e}ncia, Tecnologia e Ensino Superior (MCTES) through Fundos do Or{\c c}amento de Estado, by PTDC/BTM-SAL/32147/2017 (FCT) and by a Twinning action (SynaNet) from the EU H2020 programme (project number: 692340). N.R. was in receipt of an FCT PhD fellowship (PD/BD/113463/2015). We would like to thank to Joana E. Coelho, PhD, and Lu{\'i}sa V. Lopes, PhD, from Instituto de Medicina Molecular Jo{\~a}o Lobo Antunes, for providing the A2AR KO mouse striatum sample. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = jul,
doi = "10.1016/j.neuropharm.2020.108106",
language = "English",
volume = "171",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Ltd.",
}